{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:27:52Z","timestamp":1779190072721,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81401339"],"award-info":[{"award-number":["81401339"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2014jcyjA10023"],"award-info":[{"award-number":["cstc2014jcyjA10023"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2012jjA10077"],"award-info":[{"award-number":["cstc2012jjA10077"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing Health and Family Planning Commission","award":["20142048"],"award-info":[{"award-number":["20142048"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.clim.2016.12.001","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T04:31:39Z","timestamp":1482553899000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["CD3 + CD56 + natural killer T cell activity in children with different forms of juvenile idiopathic arthritis and the influence of etanercept treatment on polyarticular subgroup"],"prefix":"10.1016","volume":"176","author":[{"given":"Juan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2008-4275","authenticated-orcid":false,"given":"Ye","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuemei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2016.12.001_bb0005","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/rheumatology\/keh710","article-title":"Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?","volume":"44","author":"Ramanan","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.clim.2016.12.001_bb0010","doi-asserted-by":"crossref","first-page":"14757","DOI":"10.1038\/srep14757","article-title":"Identification of a FOXP3(+)CD3(+)CD56(+) population with immunosuppressive function in cancer tissues of human hepatocellular carcinoma","volume":"5","author":"Li","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2016.12.001_bb0015","doi-asserted-by":"crossref","first-page":"863625","DOI":"10.1155\/2014\/863625","article-title":"The function of CD3+CD56+ NKT-like cells in HIV infected individuals","volume":"2014","author":"Jiang","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.clim.2016.12.001_bb0020","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10067-014-2641-z","article-title":"Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis","volume":"33","author":"Aggarwal","year":"2014","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.clim.2016.12.001_bb0025","first-page":"S9","article-title":"CD3+CD56+natural killer T cells in fibromyalgia syndrome patients: association with the intensity of depression","volume":"31","author":"Nugraha","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.clim.2016.12.001_bb0030","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1002\/art.39244","article-title":"Dysregulated osteoclastogenesis is related to natural killer T cell dysfunction in rheumatoid arthritis","volume":"67","author":"Jin","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.12.001_bb0035","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2016.12.001_bb0040","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","article-title":"2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features","volume":"63","author":"Beukelman","year":"2011","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.clim.2016.12.001_bb0045","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1182\/blood-2011-02-336321","article-title":"Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity","volume":"118","author":"Pievani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2016.12.001_bb0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/157339512804806224","article-title":"Can exert opposing effects in autoimmunity, tumor surveillance and inflammation","volume":"8","author":"Viale","year":"2012","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.clim.2016.12.001_bb0055","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1172\/JCI72308","article-title":"IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset","volume":"124","author":"Sag","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2016.12.001_bb0060","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.4049\/jimmunol.1302701","article-title":"Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus","volume":"193","author":"Cho","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.12.001_bb0065","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bbrc.2009.09.008","article-title":"Natural killer T cells promote collagen-induced arthritis in DBA\/1 mice","volume":"390","author":"Jung","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2016.12.001_bb0070","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/art.21056","article-title":"The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine models","volume":"52","author":"Chiba","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.12.001_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20041400","article-title":"NKT cells promote antibody-induced joint inflammation by suppressing transforming growth factor beta1 production","volume":"201","author":"Kim","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2016.12.001_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.imlet.2007.05.004","article-title":"Macrophages express granzyme B in the lesion areas of atherosclerosis and rheumatoid arthritis","volume":"111","author":"Kim","year":"2007","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2016.12.001_bb0085","doi-asserted-by":"crossref","first-page":"R877","DOI":"10.1186\/ar1758","article-title":"Perforin deficiency attenuates collagen-induced arthritis","volume":"7","author":"Bauer","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2016.12.001_bb0090","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/ard.2003.007039","article-title":"Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis","volume":"64","author":"Goldbach-mansky","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2016.12.001_bb0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/rheumatology\/kel437","article-title":"NKT cells: manipulable managers of joint inflammation","volume":"46","author":"Coppieters","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.clim.2016.12.001_bb0100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/annrheumdis-2011-201060","article-title":"Effectiveness and safety of a second and third biological agent after failing etanercept in juvenile idiopathic arthritis: results from the Dutch National ABC Register","volume":"72","author":"Otten","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2016.12.001_bb0105","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1517\/14656560903386300","article-title":"Treatment strategies for juvenile idiopathic arthritis","volume":"10","author":"Klein","year":"2009","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.clim.2016.12.001_bb0110","doi-asserted-by":"crossref","first-page":"R493","DOI":"10.1186\/ar1695","article-title":"Peripheral blood but not synovial fluid natural killer T cells are biased towards a Th1-like phenotype in rheumatoid arthritis","volume":"7","author":"Linsen","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.clim.2016.12.001_bb0115","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis, Pediatric Rheumatology Collaborative Study Group","volume":"342","author":"Lovell","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2016.12.001_bb0120","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2011.1671","article-title":"Factors associated with treatment response to etanercept in juvenile idiopathic arthritis","volume":"306","author":"Otten","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.clim.2016.12.001_bb0125","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nrrheum.2014.140","article-title":"Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?","volume":"10","author":"Schmeling","year":"2014","journal-title":"Nat. Rev. Rheumatol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616301085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616301085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T11:56:32Z","timestamp":1536148592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616301085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":25,"alternative-id":["S1521661616301085"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2016.12.001","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD3+CD56+ natural killer T cell activity in children with different forms of juvenile idiopathic arthritis and the influence of etanercept treatment on polyarticular subgroup","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2016.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}